📰 Nasdaq Nxtc News
Nasdaq Nxtc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Nxtc. Real-time updates on events, politics, business and more.
May 4, 2024
NextCure (NASDAQ:NXTC – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at HC Wainwright in a report released on Friday, Benzinga reports. They currently have a $8.00 price target on the stock. HC Wainwright’s target price would suggest a potential upside of 422.88% from the company’s previous close. Separately, Needham & […]
April 28, 2024
Marquette Asset Management LLC acquired a new stake in shares of NextCure, Inc. (NASDAQ:NXTC – Free Report) during the 4th quarter, Holdings Channel.com reports. The firm acquired 58,259 shares of the company’s stock, valued at approximately $66,000. Separately, Acuitas Investments LLC raised its holdings in NextCure by 30.0% during the 4th quarter. Acuitas Investments LLC […]
March 28, 2024
NextCure, Inc. (NASDAQ:NXTC – Get Free Report) was the target of a significant growth in short interest in March. As of March 15th, there was short interest totalling 839,700 shares, a growth of 579.9% from the February 29th total of 123,500 shares. Based on an average trading volume of 229,500 shares, the short-interest ratio is […]
February 14, 2024
NextCure, Inc. (NASDAQ:NXTC – Get Free Report) was the target of a significant decrease in short interest during the month of January. As of January 31st, there was short interest totalling 108,900 shares, a decrease of 11.8% from the January 15th total of 123,400 shares. Based on an average daily volume of 91,000 shares, the […]
December 21, 2023
BELTSVILLE, Md., Dec. 21, 2023 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and...
December 14, 2023
NextCure, Inc. (NASDAQ:NXTC – Get Free Report)’s stock price dropped 1.1% during trading on Monday . The stock traded as low as $1.30 and last traded at $1.34. Approximately 117,807 shares traded hands during trading, an increase of 79% from the average daily volume of 65,754 shares. The stock had previously closed at $1.35. NextCure […]
November 27, 2023
NextCure (NASDAQ:NXTC – Get Free Report) and NGM Biopharmaceuticals (NASDAQ:NGM – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, valuation, risk, analyst recommendations and earnings. Insider & Institutional Ownership 47.8% of NextCure shares […]
November 14, 2023
NextCure, Inc. (NASDAQ:NXTC – Get Free Report)’s share price traded up 0.9% during trading on Monday . The company traded as high as $1.20 and last traded at $1.12. 124,661 shares traded hands during trading, an increase of 88% from the average session volume of 66,242 shares. The stock had previously closed at $1.11. Analyst […]
August 9, 2023
HC Wainwright initiated coverage on shares of NextCure (NASDAQ:NXTC – Free Report) in a report issued on Tuesday morning, MarketBeat reports. The brokerage issued a buy rating and a $7.00 price objective on the stock. Separately, Needham & Company LLC reaffirmed a buy rating and set a $6.00 price target on shares of NextCure in […]
July 29, 2023
NextCure, Inc. (NASDAQ:NXTC – Get Free Report) was the recipient of a large decline in short interest during the month of July. As of July 15th, there was short interest totalling 221,600 shares, a decline of 17.9% from the June 30th total of 269,800 shares. Currently, 1.1% of the company’s shares are short sold. Based […]